Skip to main content

Animations

MJFF Publications

4591 - 4600 of 6422 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2022
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16180
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Assessment tools for cognitive performance in Parkinson’s disease and its genetic contributors
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1413187
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.52089
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Single cell transcriptomes and multiscale networks from persons with and without Alzheimer’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49790-0
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-024-50686-2
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Epistatic Features and Machine Learning Improve Alzheimer’s Disease Risk Prediction Over Polygenic Risk Scores
    Journal Name: Journal of Alzheimer’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-230236
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.008
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-48961-3
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline
    Journal Name: BMJ Mental Health
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjment-2024-301062
    Citation Count: 8
  • Summary Details
    OPEN
    Title: RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00121-2
    Citation Count: 64
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.